Complete response to weekly carboplatin-docetaxel chemotherapy in a 91-year-old woman with anaplastic thyroid cancer

Haralabos Koussis, Carlo Alberto Giorgi, Elisabetta Di Liso, Maria Concetta Carlucci, Ambrogio Fassina, Gino Marioni, Pier Franco Conte

Research output: Contribution to journalArticlepeer-review

Abstract

Anaplastic thyroid cancer (ATC) is an unusual tumor with the worst prognosis among thyroid malignancies. Treatment of the patients diagnosed with ATC is not standardized and the feasible options include surgery, radiotherapy and chemotherapy. ATC cannot be regarded as a very chemo-sensitive tumor. Herein, we reported a case of a 91-year-old woman with complete response after induction chemotherapy (weekly carboplatin and docetaxel) that underwent subsequent radiotherapy.

Original languageEnglish
Pages (from-to)268-272
Number of pages5
JournalAmerican Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume36
Issue number2
DOIs
Publication statusPublished - Mar 1 2015

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Medicine(all)

Fingerprint Dive into the research topics of 'Complete response to weekly carboplatin-docetaxel chemotherapy in a 91-year-old woman with anaplastic thyroid cancer'. Together they form a unique fingerprint.

Cite this